Abstract

The application of digital monitoring biomarkers in health, wellness and disease management is reviewed. Harnessing the near limitless capacity of these approaches in the managed healthcare continuum will benefit from a systems-based architecture which presents data quality, quantity, and ease of capture within a decision-making dashboard. A framework was developed which stratifies key components and advances the concept of contextualized biomarkers. The framework codifies how direct, indirect, composite, and contextualized composite data can drive innovation for the application of digital biomarkers in healthcare. The de novo framework implies consideration of physiological, behavioral, and environmental factors in the context of biomarker capture and analysis. Application in disease and wellness is highlighted, and incorporation in clinical feedback loops and closed-loop systems is illustrated. The study of contextualized biomarkers has the potential to offer rich and insightful data for clinical decision making. Moreover, advancement of the field will benefit from innovation at the intersection of medicine, engineering, and science. Technological developments in this dynamic field will thus fuel its logical evolution guided by inputs from patients, physicians, healthcare providers, end-payors, actuarists, medical device manufacturers, and drug companies.

Highlights

  • The application of digital monitoring biomarkers in health, wellness and disease management is reviewed

  • Despite concerted efforts the translation and adoption of biomarkers as clinically validated surrogate endpoints of disease has moved at a relatively conservative pace [5]

  • Established in 2014, its expressed mission is to create standards that can be used for evidence-based biomarker development, and their subsequent adoption to advance precision medicine [7]

Read more

Summary

RESEARCH METHODS AND TECHNOLOGY REVIEW ARTICLE

Can composite digital monitoring biomarkers come of age? Kourtis1†, Marie Schiller, Howard Wolpert, Rhett G. Journal of Clinical and Translational Science (2017), 1, pp. Journal of Clinical and Translational Science (2017), 1, pp. 373–380 doi:10.1017/cts.2018.4

Introduction
Methods
Results
Conclusions
Introduction and Current State
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call